Jasper Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	344	88	18	297	125	126
Market Cap Growth	123.39%	379.94%	-93.83%	137.48%	-0.60%	-
Enterprise Value	227	4	-17	215	107	99
PE Ratio	-	-1.37	-0.49	-9.70	-3.95	-25.24
PB Ratio	3.03	1.12	0.51	4.27	-3.56	-26.59
P/FCF Ratio	-7.66	-1.68	-0.40	-8.23	-6.85	-63.93
P/OCF Ratio	-7.70	-1.69	-0.40	-8.82	-6.85	-63.93
EV/EBITDA Ratio	-5.23	-0.06	0.46	-7.15	-3.37	-22.16
EV/EBIT Ratio	-5.10	-0.05	0.44	-7.02	-3.36	-22.16
EV/FCF Ratio	-5.65	-0.07	0.36	-5.95	-5.83	-50.13
Debt / Equity Ratio	0.02	0.04	0.10	0.04	-0.05	-
Debt / EBITDA Ratio	-0.04	-0.04	-0.10	-0.10	-0.05	-
Debt / FCF Ratio	-0.04	-0.05	-0.08	-0.08	-0.09	-
Quick Ratio	13.33	7.06	5.57	10.60	5.18	13.63
Current Ratio	13.49	7.19	5.91	10.95	5.16	13.63
Interest Coverage	-	-	-	-	-	-8.36
Return on Equity (ROE)	-64.60%	-63.20%	-71.60%	-240.40%	629.30%	-
Return on Assets (ROA)	-56.20%	-55.10%	-58.30%	-47.90%	-38.60%	-
Return on Capital (ROIC)	-60.45%	-84.78%	-129.15%	-50.87%	61.73%	99.49%
Earnings Yield	-18.60%	-73.23%	-205.45%	-10.31%	-25.31%	-3.96%
FCF Yield	-16.80%	-59.45%	-253.15%	-12.15%	-14.60%	-1.56%
Buyback Yield / Dilution	-51.74%	-186.15%	-220.19%	-85.99%	-35.80%	-
Total Shareholder Return	-51.74%	-186.15%	-220.19%	-85.99%	-35.80%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).